Product NDC: | 0025-2011 |
Proprietary Name: | Covera-HS |
Non Proprietary Name: | verapamil hydrochloride |
Active Ingredient(s): | 180 mg/1 & nbsp; verapamil hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0025-2011 |
Labeler Name: | G.D. Searle LLC Division of Pfizer Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020552 |
Marketing Category: | NDA |
Start Marketing Date: | 19960226 |
Package NDC: | 0025-2011-31 |
Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0025-2011-31) |
NDC Code | 0025-2011-31 |
Proprietary Name | Covera-HS |
Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0025-2011-31) |
Product NDC | 0025-2011 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | verapamil hydrochloride |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 19960226 |
Marketing Category Name | NDA |
Labeler Name | G.D. Searle LLC Division of Pfizer Inc |
Substance Name | VERAPAMIL HYDROCHLORIDE |
Strength Number | 180 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |